The news release reads, in part, "This collaboration brings together Cost Plus Drugs' groundbreaking transparent pricing model and 9amHealth's high-touch, at a time where patient demand and rising medical costs have come to a head." In the TL;DR summary, this means that Cost Plus is teaming up with 9amHealth to bring cheaper obesity meds and real, expert-led care to employer health plans
GLP-1 agonists also affect the digestive system
Semaglutide works well, but newer research compares it to tirzepatide (sold as Mounjaro for diabetes, Zepbound for weight management)
For example, in Ozempic trials, only 0.6% of patients on the 0.5 mg dose reported injection site reactions like bruising, and most cases resolved within a week or two
Melanotan-2 is a different story
Weeks 5 through 8: 0.5 mg semaglutide per week